
ï“

Editorial: What laboratory medicine can learn from Wal Timmy in terms of resilience

by | Apr 14, 2026 | Featured, Health, Politics, Research

The humpback whale Timmy stranded several times in the shallow Wismar Bay. The animal suffered for weeks from skin damage due to the low salt content, pressure necrosis, lung compression, hyperthermia and organ stress due to its own weight. Several expert reports did not attest to a realistic chance of survival. Any further intervention would have caused additional suffering. Section 1 sentence 1 of the Animal Welfare Act (TierSchG) prohibits inflicting pain, suffering or damage on an animal without reasonable cause. § 2 specifies the responsibility of humans for the animal as a fellow creature. § 4 regulates protection against unreasonable burdens. Section 17 makes it a punishable offence to inflict significant, prolonged or recurrent considerable pain or suffering on vertebrates – even by omission in the case of an existing guarantor position. Private rescue initiatives failed due to a lack of permits, required additional expert opinions and rejected urgent applications. A ban mile and investigations underlined the strict adherence to procedural rules. Critics accused that passive waiting despite progressive suffering itself violated the prohibition of persistent suffering in the Animal Protection Act and that the existing animal welfare laws could therefore not be fully enforced in practice.

Timmy must continue to suffer. Symbolic image. Credits: Unsplash
Timmy must continue to suffer. Symbolic image. Credits: Unsplash

This scenario illustrates how strict legal protections in acute emergencies delay or prevent pragmatic solutions. The intention of the Animal Protection Act to minimise suffering comes into conflict with the reality of a deteriorating situation through bureaucratic processes, clarifications of jurisdiction and judicial hurdles.

Laboratory medicine, as part of the critical infrastructure in the healthcare system, can learn from this. Laboratories process samples daily for diagnostics, transfusion medicine, infection monitoring and emergency analyses. A hybrid attack – cyber attack on LIMS systems, power failure or physical sabotage – leaves them “stranded”: equipment fails, sample logistics collapses, and there are no findings for intensive care units, emergency rooms or disease control. The consequence would be delayed treatment decisions with direct effects on patients.

Similar to the whale, existing laws and regulations have a delaying effect. The In Vitro Diagnostic Medical Device Regulation (IVDR, EU 2017/746) requires a quality management system and strict validation of new or improvised procedures in Article 5 (5) for in-house IVDs. The Medical Devices Regulation (MDR, EU 2017/745) and the Medical Devices Implementation Act (MPDG) set comparable requirements for devices and their conversion. Article 9 of the General Data Protection Regulation (GDPR) regulates the processing of health data with narrow exceptions; fast analogue data exchange or simplified documentation could be considered a violation. Accreditation according to DIN EN ISO 15189 requires complete quality management – any deviation from validated processes must be strictly documented and justified. The Infection Protection Act (IfSG) obliges reporting obligations and coordination in special situations (§§ 4 et seq., section on ensuring public health). The KRITIS Umbrella Act (Act to Strengthen the Resilience of Critical Infrastructures) and Section 8a BSIG (BSI Act) prescribe appropriate organisational and technical measures for risk prevention, reporting obligations and verification for operators of critical infrastructures in the health sector. Laboratories with a high volume of samples (threshold value of 1.5 million orders/year, among other things) fall under these regulations. In practice, these requirements mean that pragmatic emergency solutions – such as pre-trained analogue backup processes, decentralised sample processing or improvised manual methods – can only be implemented after extensive testing, coordination with regulatory authorities and documentation, while diagnostics fail and patient care suffers.

Laboratory medicine can already arm itself today by systematically defusing such mechanisms. This includes pre-validated and accreditation-compliant backup procedures for core analyses (blood count, blood gas, CRP, coagulation, infection parameters), which can be used in an emergency without violating IVDR, ISO 15189 or RiliBÄK . Redundant power and IT supplies disconnected from the main grid with emergency generators and physically separate systems reduce dependencies. Stockpiling of critical reagents and standardized interfaces to neighboring laboratories enable decentralized capacities. Risk analyses according to KRITIS specifications and the industry-specific safety standard for medical care must explicitly include hybrid scenarios and contain clear escalation levels with predefined scope for action. Regular exercises simulate blackouts, ransomware or supply chain failures and test whether pragmatic measures work within the legal limits (IfSG, GDPR, IVDR). Internal decision-making powers for local specialists and standardised emergency agreements with supervisory authorities shorten coordination times. In addition, the integration of resilience into the quality management system according to ISO 15189 strengthens continuous review.

The drama surrounding Wal Timmy makes it clear that the rigid application of protective laws such as the Animal Protection Act can prevent exactly what they are supposed to protect in emergency situations – the avoidance of suffering. Laboratory medicine gains decisive room for manoeuvre if it builds resilience in such a way that pragmatic solutions do not fail because of procedural hurdles. This ensures the functionality of diagnostics and thus patient care even under hybrid stress.

Vlad Georgescu commented.

Read Also:

Wal Timmy: Germany’s problem with euthanasia – MedLabPortal

GOÄ reform endangers the resilience of laboratory medicine as a critical infrastructure – MedLabPortal


Editor: X-Press Journalistenbüro GbR

Gender Notice. The personal designations used in this text always refer equally to female, male and diverse persons. Double/triple naming and gendered designations are used for better readability. ected.

X
Ich bin Invi, wie kann ich dir helfen?